Patients with heart failure and a leaking heart valve reported feeling better and experiencing fewer heart failure symptoms if they underwent a procedure to repair their valve than patients who received standard treatment alone, according to research presented at the American College of Cardiology’s 68th Annual Scientific Session. The findings are the latest to come […]Continue Reading ...
A new imaging method provides structural information about brain tissue that was previously difficult to access. Diattenuation Imaging (DI), developed by scientists at Forschungszentrum Jülich and the University of Groningen, allows to differentiate, e.g., regions with many thin nerve fibers from regions with few thick nerve fibers. With current imaging methods, these tissue types cannot […]Continue Reading ...
Milk can be lethal to babies with classic galactosemia, a rare genetic disorder that severely impairs the body’s ability to process a milk sugar known as galactose and is associated with a host of neurodevelopmental issues. However, the fate of children with Duarte galactosemia-;a milder, more common variant-;has been unclear. As a result, state-level recommendations […]Continue Reading ...
Credit: CC0 Public Domain The higher the cotinine levels were in the mother’s blood during pregnancy, the greater was the child’s risk of developing attention deficit hyperactivity disorder (ADHD) later in life, showed an epidemiological study conducted by the Research Centre for Child Psychiatry at the University of Turku in Finland. Globally, it is the […]Continue Reading ...
“The major thing is, of course, the rapid effect,” said Dr. Margaret Spinelli, a clinical professor of psychiatry at Columbia University.Continue Reading ...
Pills or oral medications contain inactive ingredients such as gluten that may be responsible for dangerous side effects, concludes a new study. The research appeared in the latest issue of the journal Science Translational Medicine. The researchers explain that the allergic reactions to the pills may be due to inactive ingredients that make up the […]Continue Reading ...
What began with a modest hospital grant at the University of Michigan in 1996 is now the world’s leading source of data on diagnosis, treatments and outcomes for a rare and dangerous cardiac condition. On Monday, Kim Eagle, M.D., a director of U-M’s Frankel Cardiovascular Center, presented data from 9,000 patients gathered over nearly 25 […]Continue Reading ...
A new study by researchers at The University of Texas at Dallas, UT MD Anderson Cancer Center, UT Health Science Center at Houston and Baylor College of Medicine has produced evidence of the source of chronic pain in humans, revealing several new targets for pain treatment. The paper — published March 19 in Brain, one […]Continue Reading ...
Sixty million kids participate in organized athletics each year with ever increasing amounts of children specializing in one sport before the age of 14 with hopes of a college scholarship or professional career on the line. However, researchers presenting their work at the AOSSM/AANA Specialty Day today reveal that this early intense participation might come […]Continue Reading ...
ubrogepant Treatment for Migraine Allergan Announces FDA Acceptance of New Drug Application for Ubrogepant for the Acute Treatment of Migraine DUBLIN, March 11, 2019 /PRNewswire/ — Allergan plc (NYSE: AGN) today announced that the U.S. Food and Drug Administration (FDA) has accepted the company’s New Drug Application (NDA) for ubrogepant for the acute treatment of […]Continue Reading ...
Salvatierra served in the U.S. Army Medical Corps in Vietnam and worked as a physician in Pomona, California, before beginning a postdoctoral fellowship in transplant surgery at the University of California-San Francisco in 1972. The first successful kidney transplant had been performed in 1954, and by 1972, the year that Medicare coverage was expanded to […]Continue Reading ...
The latest ECDC-WHO report Tuberculosis surveillance and monitoring in Europe 2019 (2017 data) shows that despite an overall decline in numbers of people suffering from TB, the disease remains a major public health challenge in the Region. Of the 275 000 new diagnoses and relapses, an estimated 77 000 people are suffering from difficult-to-treat multidrug-resistant […]Continue Reading ...
Researchers from the University of Oulu and Harvard University have found a previously unknown mechanism by which cells in the body sense oxygen. Lack of oxygen had a direct influence on the functioning of genes, and prevented cell differentiation. This observation will open up new opportunities for the development of cancer drugs. The study was […]Continue Reading ...
Breast cancer survivors like many other cancer survivors live in fear of relapse of their cancer after they have been in remission. Researchers have now developed a tool by which they can predict accurately the time when the cancer is likely to return. The results of this study were published in the latest issue of […]Continue Reading ...
In the largest randomized controlled trial of treatment for high blood pressure ever conducted in sub-Saharan Africa, two frontline two-drug combinations that included the long-acting calcium channel blocker, amlodipine, were able to drive down blood pressure levels more than a third two-drug combination that did not include amlodipine, according to research presented at the American […]Continue Reading ...
- Leaky valve repair improves quality of life in heart failure patients
- Diattenuation Imaging offers structural information of difficult to access brain regions
- Early sports specialization linked to increased injury rates during athletic career
- Study brings clarity about milk intake for children with Duarte galactosemia
- Allergan Announces FDA Acceptance of New Drug Application for Ubrogepant for the Acute Treatment of Migraine
- Maternal smoking during pregnancy increases risk of ADHD among offspring up to three-fold
- Pioneering pediatric kidney transplant surgeon Oscar Salvatierra dies at 83 | News Center
- F.D.A. Approves First Drug for Postpartum Depression
- TB remains a major public health challenge in the European region
- Most pills contain common allergens, warn experts
- Researchers discover previously unknown mechanism by which cells can sense oxygen
- World’s leading source of data on diagnosis, treatments for aortic dissection
- Breast cancer relapse predictor may soon be a reality
- Researchers identify origin of chronic pain in humans
- Two-drug combinations containing calcium channel blocker significantly lowers BP
- King’s scientists to monitor air quality exposure of 250 children
- Preventative cardioverter defibrillator implantation is of little benefit to kidney dialysis patients
- Merck to collaborate with GenScript for plasmid and virus manufacturing in China
- FDA Approves Zulresso (brexanolone) for the Treatment of Postpartum Depression
- Study examines long-term opioid use in patients with severe osteoarthritis